Oncotarget

Research Papers:

NDRG4, a novel candidate tumor suppressor, is a predictor of overall survival of colorectal cancer patients

Dake Chu, Zixi Zhang, Yi Zhou, Yunming Li, Shaojun Zhu, Jian Zhang, Qingchuan Zhao, Gang Ji, Weizhong Wang and Jianyong Zheng _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2015; 6:7584-7596. https://doi.org/10.18632/oncotarget.3170

Metrics: PDF 1283 views  |   HTML 1423 views  |   ?  


Abstract

Dake Chu1,2,*, Zixi Zhang3,*, Yi Zhou4,*, Yunming Li5, Shaojun Zhu6, Jian Zhang2, Qingchuan Zhao1, Gang Ji1, Weizhong Wang1, Jianyong Zheng1

1State Key Laboratory of Cancer Biology and Xijing Hospital of Digestive Diseases, Xijing Hospital, Fourth Military Medical University, Xi'an, China

2State Key Laboratory of Cancer Biology, Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi'an, China

3Department of Plastic Surgery, Xijing Hospital, Fourth Military Medical University, Xi'an, China

4Department of Gastrointestinal Surgery, Tianjin Union Medical Center, Tianjin, China

5Statistics Office, Chengdu Military General Hospital, Chengdu, Sichuan Province, China

6Department of Pathology, Fourth Military Medical University, Xi'an, China

*These authors have contributed equally to this work

Correspondence to:

Jianyong Zheng, e-mail: zhjy68@163.com

Dake Chu, e-mail: chudake@hotmail.com

Keywords: NDRG4, PI3K-AKT, colorectal cancer, carcinogenesis, progression

Received: December 16, 2014     Accepted: January 19, 2015     Published: February 05, 2015

ABSTRACT

The role of NDRG4 in human malignancies is largely unknown. We investigated the role of NDRG4 protein in colorectal cancer and its prognostic value in a hospital-based retrospective training cohort of 272 patients and a prospective validation cohort of 708 patients were. Cell line was transfected with an NDRG4 expression construct to confirm the suppression of PI3K-AKT activity by NDRG4. Appropriate statistical methods were utilized for analysis. Results showed that NDRG4 protein expression was significantly decreased from normal mucosa, chronic colitis, ulcerative colitis, atypical hyperplasia to colorectal cancer. Significant negative correlations were found between NDRG4 staining and p-AKT. Patients with positive NDRG4 staining had favorable survival in both study cohorts. In multivariate analysis, NDRG4 staining proved to be an independent predictor of overall survival. Moreover, the prognostic role of NDRG4 was stratified by p-AKT. Overexpression of NDRG4 in colorectal cancer cell can significantly suppress PI3K-AKT activity, even after EGF stimulation. These results indicated NDRG4 protein expression was decreased in colorectal cancer. It may play its tumor suppressive role in carcinogenesis and progression through attenuation of PI3K-AKT activity. Therefore, high risk colorectal cancer patients could be better identified based on the combination of NDRG4 and PI3K-AKT activity.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 3170